Overview
- 6 FDA inspections are on record.
- 5 inspections produced a Form 483.
- The most recent recorded inspection date is 2025-12-18.
At a glance
Inspections
6
Form 483s
5
EIRs
0
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 8 Dec 2025 – 18 Dec 2025 | Foods & Cosmetics | 483 | View 483 → |
| 8 Oct 2024 – 24 Oct 2024 | Foods & Cosmetics | 483 | View 483 → |
| 26 Feb 2019 – 7 Mar 2019 | Medical Devices & Rad Health | Clean | |
| 12 Sep 2016 – 16 Sep 2016 | Medical Devices & Rad Health | 483 | View 483 → |
| 14 Jan 2014 – 21 Jan 2014 | Medical Devices & Rad Health | 483 | View 483 → |
| 20 Jul 2012 | Not recorded | WL | View 483 → |
Observations on record
Form 483 observations cited at this site, most recent first.
18 Dec 2025
21 CFR 111.103
Written procedures - follow; quality control operations
Cited by Stephanie L Kelly, Gates E Raynor, Janaysia N Trail
18 Dec 2025
21 CFR 111.105(a)
Quality control - processes, specifications, written procedures
Cited by Stephanie L Kelly, Gates E Raynor, Janaysia N Trail
18 Dec 2025
21 CFR 111.120(e)
Quality control operations - quarantine
Cited by Stephanie L Kelly, Gates E Raynor, Janaysia N Trail
18 Dec 2025
21 CFR 111.123(a)(6)
Quality control operations - in-process specifications
Cited by Stephanie L Kelly, Gates E Raynor, Janaysia N Trail
18 Dec 2025
21 CFR 111.210
Master manufacturing record - record requirements
Cited by Stephanie L Kelly, Gates E Raynor, Janaysia N Trail
Investigators
FDA investigators tied to this site in the record.
Joseph F Owens2 insp.
Tamara J Henderson2 insp.
Stephanie L Kelly1 insp.
Gates E Raynor1 insp.
Janaysia N Trail1 insp.
Alexis S Roberts1 insp.
Miaja Umaedi1 insp.
Susan O Oladeji1 insp.
Nije A Thomas1 insp.
Babatunde D Babalola1 insp.
Seneca D Toms1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 111.70(e) | Cited across public-safe Form 483 observations | 5x |
| 21 CFR 111.315(d) | Cited across public-safe Form 483 observations | 4x |
| 21 CFR 211.100(a) | Cited across public-safe Form 483 observations | 4x |
| 21 CFR 211.160(b) | Cited across public-safe Form 483 observations | 4x |
| 21 CFR 211.165(b) | Cited across public-safe Form 483 observations | 4x |
| 21 CFR 211.166(a) | Cited across public-safe Form 483 observations | 4x |
| 21 CFR 803.17 | Cited across public-safe Form 483 observations | 4x |
| 21 CFR 820.100(a) | Cited across public-safe Form 483 observations | 4x |
| 21 CFR 820.20(e) | Cited across public-safe Form 483 observations | 4x |
| 21 CFR 820.75(a) | Cited across public-safe Form 483 observations | 4x |
| 21 CFR 111.65 | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 111.70(b)(2) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 111.105(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 111.120(e) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 111.205(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 111.210 | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 111.260 | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 111.70(b) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 111.75(a)(1)(i) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 111.103 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 111.123(a)(6) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 111.130(a)(1) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 111.14(b)(1) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 111.140(b)(1) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 111.16 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 111.205(b)(1) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 111.255(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 111.255(c) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 111.27(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 111.375(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 111.553 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 111.570(b)(1) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 111.70(d) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 111.70(g) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 111.75(c) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 114.83 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.130 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.198(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 820.198(a) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Meta Labs Pharmaceuticals, LLC's 5 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat